17β-estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptor

Cancer Cell International

Volumn 3, Issue , 2003, Pages

  Hamelers, Irene H L ^a   van Schaik, Richard F M A ^a   Sussenbach, John S ^a   Steenbergh, Paul H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; AUTOCRINE MOTILITY FACTOR; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; INSULIN RECEPTOR ANTIBODY; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; SURAMIN;

ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL CULTURE; CANCER PREVENTION; CANCER THERAPY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN ACTIVITY; HORMONE INHIBITION; HORMONE RESPONSE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; MITOGENICITY; PROTEIN SECRETION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 2942608091     PISSN: 14752867     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2867-3-10     Document Type: Article

References (28)

1. Dupont J and Le Roith D: Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects Mol Pathol 2001, 54:149-154.
2. Lai A, Sarcevic B, Prall OW and Sutherland RL: Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1) J Biol Chem 2001, 276:25823-25833.
3. Keshamouni VG, Mattingly RR and Reddy KB: Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells: A role for HER2 and PKC-delta J Biol Chem 2002, 277:22558-22565.
4. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D and Migliaccio A et al.: Non-transcriptional action of oestradiol and progestin triggers DNA synthesis EMBO J 1999, 18:2500-2510.
5. Ahmad S, Singh N and Glazer RI: Role of AKT1 in 17β-estradioland insulin-like growth factor I (IGE-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells Biochem Pharmacol 1999, 58:425-430.
6. Edwards DP and McGuire WL: Estrogen action in human breast cancer Anticancer Res 1982, 2:297-308.
7. Jozan S, Moure C, Gillois M and Bayard F: Effects of estrone on cell proliferation of a human breast cancer (MCF-7) in long term tissue culture J Steroid Biochem 1979, 10:341-342.
8. Shafie SM: Estrogen and the growth of breast cancer: new evidence suggests indirect action Science 1980, 209:701-702.
9. Van der Burg B, Rutteman GR, Blankenstein MA, De Laat SW and Van Zoelen EJJ: Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen J Cell Physiol 1988, 134:101-108.
10. Hamelers IHL, van Schaik RFMA, van Teeffelen HAAM, Sussenbach JS and Steenbergh PH: Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells Exp Cell Res 2002, 273:107-117.
11. Hamelers IHL, van Schaik RFMA, Sipkema J, Sussenbach JS and Steenbergh PH: Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells J Biol Chem 2002, 277:47645-47652.
12. Berns EM, Schuurmans AL, Bolt J, Lamb DJ, Foekens JA and Mulder E: Antiproliferative effects of suramin on androgen responsive tumour cells Eur J Cancer 1990, 26:470-474.
13. La Rocca RV, Danesi R, Cooper MR, Jamis-Dow CA, Ewing MW and Linehan WM et al.: Effect of suramin on human prostate cancer cells in vitro J Urol 1991, 145:393-398.
14. Reed E, Cooper MR, LaRocca RV, Bostick-Bruton F and Myers CE: Suramin in advanced platinum-resistant ovarian cancer Eur J Cancer 1992, 28A:864-866.
15. Vignon F, Prebois C and Rochefort H: Inhibition of breast cancer growth by suramin J Natl Cancer Inst 1992, 84:38-42.
16. Stein CA, LaRocca RV, Thomas R, McAtee N and Myers CE: Suramin: an anticancer drug with a unique mechanism of action J Clin Oncol 1989, 7:499-508.
17. Ravera F, Miglietta L, Pirani P, Ferrini S and Favoni RE: Suramininduced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events Eur J Cancer 1993, 29A:225-230.
18. Wade TP, Kasid A, Stein CA, LaRocca RV, Sargent ER and Gomella LG et al.: Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture J Surg Res 1992, 53:195-198.
19. de Vente JE, Kukoly CA, Bryant WO, Posekany KJ, Chen J and Fletcher DJ et al.: Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd45 in initiating death J Clin Invest 1995, 96:1874-1886.
20. Dufourny B, Alblas J, Van Teeffelen HAAM, Van Schaik FMA, Van der Burg B and Steenbergh PH et al.: Mitogenic signaling of insulinlike growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase J Biol Chem 1997, 272:31163-31171.
21. Van der Burg B, Isbrucker L, Selm-Miltenburg AJ, De Laat SW and Van Zoelen EJ: Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells Cancer Res 1990, 50:7770-7774.
22. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE and Cullen KJ et al.: Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer Mol Endocrinol 1989, 3:509-517.
23. Gebauer G, Jäger W and Lang N: mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells Anticancer Res 1998, 18:1191-1195.
24. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B and Schwartz A et al.: Insulin-like growth factor II mRNA expression in human breast cancer Cancer Res 1988, 48:6691-6696.
25. Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA and Ramasharma K et al.: Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor Mol Endocrinol 1989, 3:1701-1709.
26. Arteaga CL and Osborne CK: Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor Cancer Res 1989, 49:6237-6241.
27. Soule HD, Vazguez J, Long A, Albert S and Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma J Natl Cancer Inst 1973, 51:1409-1416.
28. Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L and Mordoh J: Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer Proc Natl Acad Sci U S A 1987, 84:7295-7299.